| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 344.46B | 339.66B | 309.08B | 323.70B | 250.03B | 226.46B |
| Gross Profit | 45.10B | 40.50B | 42.89B | 40.59B | 27.32B | 30.39B |
| EBITDA | 16.85B | 14.06B | 17.37B | 17.00B | 3.98B | 8.09B |
| Net Income | 12.37B | 10.52B | 9.11B | 7.79B | 1.91B | 3.37B |
Balance Sheet | ||||||
| Total Assets | 179.49B | 185.72B | 180.87B | 174.00B | 155.17B | 145.19B |
| Cash, Cash Equivalents and Short-Term Investments | 39.68B | 42.63B | 33.13B | 32.54B | 21.50B | 25.48B |
| Total Debt | 24.34B | 27.08B | 28.80B | 26.25B | 17.24B | 12.96B |
| Total Liabilities | 80.67B | 87.03B | 80.96B | 81.11B | 67.48B | 51.90B |
| Stockholders Equity | 98.70B | 98.58B | 99.86B | 92.87B | 87.27B | 92.91B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 13.70B | 4.73B | 6.32B | 2.36B | 3.76B |
| Operating Cash Flow | 0.00 | 17.97B | 10.54B | 12.46B | 5.01B | 5.34B |
| Investing Cash Flow | 0.00 | 586.00M | -9.41B | -7.93B | -8.42B | -3.52B |
| Financing Cash Flow | 0.00 | -8.84B | -1.89B | 5.46B | -759.00M | -4.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥93.48B | 8.92 | ― | 3.16% | 3.28% | 20.32% | |
74 Outperform | ¥127.24B | 17.49 | ― | 2.57% | 7.46% | 153.98% | |
68 Neutral | ¥1.81T | 21.95 | 2.23% | 3.07% | -7.68% | -73.03% | |
67 Neutral | ¥74.24B | 32.15 | ― | 1.37% | -5.02% | 186.97% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | ¥218.65B | 12.70 | ― | 3.45% | -4.87% | 26.27% | |
56 Neutral | ¥3.63T | 11.54 | -0.15% | 2.74% | -14.13% | 33.18% |